Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.14 - $12.49 $18,420 - $1.64 Million
131,575 Added 660.38%
151,499 $22,000
Q3 2022

Nov 10, 2022

BUY
$8.51 - $13.6 $1,455 - $2,325
171 Added 0.87%
19,924 $209,000
Q2 2022

Aug 12, 2022

BUY
$7.31 - $11.85 $144,394 - $234,073
19,753 New
19,753 $192,000
Q4 2021

Feb 14, 2022

SELL
$4.19 - $9.56 $89,544 - $204,306
-21,371 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$3.56 - $4.64 $5,578 - $7,270
-1,567 Reduced 6.83%
21,371 $99,000
Q2 2021

Aug 16, 2021

SELL
$3.95 - $5.41 $73,628 - $100,842
-18,640 Reduced 44.83%
22,938 $99,000
Q1 2021

May 14, 2021

SELL
$4.52 - $7.8 $198,229 - $342,076
-43,856 Reduced 51.33%
41,578 $220,000
Q4 2020

Feb 12, 2021

BUY
$4.37 - $9.46 $163,022 - $352,905
37,305 Added 77.51%
85,434 $602,000
Q3 2020

Nov 13, 2020

BUY
$8.56 - $26.93 $209,377 - $658,707
24,460 Added 103.34%
48,129 $436,000
Q2 2020

Aug 12, 2020

BUY
$21.21 - $31.55 $117,545 - $174,850
5,542 Added 30.57%
23,669 $650,000
Q1 2020

May 13, 2020

SELL
$18.43 - $38.04 $519,836 - $1.07 Million
-28,206 Reduced 60.88%
18,127 $399,000
Q4 2019

Feb 12, 2020

BUY
$29.6 - $43.71 $989,113 - $1.46 Million
33,416 Added 258.7%
46,333 $1.75 Million
Q3 2019

Nov 12, 2019

BUY
$29.87 - $42.22 $101,319 - $143,210
3,392 Added 35.61%
12,917 $399,000
Q2 2019

Aug 14, 2019

BUY
$31.16 - $39.46 $3,116 - $3,946
100 Added 1.06%
9,525 $376,000
Q1 2019

May 14, 2019

BUY
$19.96 - $38.62 $188,123 - $363,993
9,425 New
9,425 $364,000

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.